Cybin (HELP) Profit After Tax (2020 - 2026)
Cybin (HELP) posted Profit After Tax of -$47.0 million for Q1 2026, down 10.14% on a QoQ basis from -$42.7 million in Q4 2025, and up 40.35% year-over-year from -$33.5 million in Q1 2025.
Cybin (HELP) Profit After Tax (2020 - 2026) Analysis & Trends
Cybin's Profit After Tax history runs 7 years deep, the most recent figure standing at -$47.0 million for Q1 2026.
- Quarterly Profit After Tax rose 40.35% year-over-year to -$47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.0 million (down 15.38% YoY) and the FY2026 annual result came in at -$148.0 million, down 81.35% from the prior year.
- Profit After Tax was -$47.0 million for Q1 2026 at Cybin, down from -$42.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $19.8 million in Q1 2023 and bottomed at -$78.8 million in Q1 2025.
- A 5-year average of -$15.5 million and a median of -$1.2 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 99.93% — and 2024, when it slumped 472630.46%.
- Cybin's Profit After Tax stood at -$10742.0 in 2022, then slumped by 107.4% to -$22278.5 in 2023, then slumped by 33739.86% to -$7.5 million in 2024, then tumbled by 465.96% to -$42.7 million in 2025, then slipped by 10.14% to -$47.0 million in 2026.
- Business Quant data shows HELP's Profit After Tax at -$47.0 million in Q1 2026, -$42.7 million in Q4 2025, and -$33.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - | -47.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.00 Mn |
| Dec 31, 2025 | -42.67 Mn |
| Sep 30, 2025 | -33.72 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Mar 31, 2025 | -78.79 Mn |
| Dec 31, 2024 | -7.54 Mn |
| Sep 30, 2024 | -41.93 Mn |
| Jun 30, 2024 | -14,824.00 |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -22,278.46 |
| Sep 30, 2023 | -8,869.11 |
| Jun 30, 2023 | -10.80 Mn |
| Feb 28, 2023 | 19.80 Mn |
| Dec 31, 2022 | -10,742.00 |
| Sep 30, 2022 | -9,973.00 |
| May 31, 2022 | 4.55 Mn |
| Mar 31, 2022 | -18,097.00 |
| Dec 31, 2021 | -17,210.00 |
| Sep 30, 2021 | -13.99 Mn |
| Jun 30, 2021 | -11,972.68 |